Literature DB >> 9848019

Searching for the cause of the increase in asthma.

S E Crater1, T A Platts-Mills.   

Abstract

The prevalence of asthma has increased dramatically over the last 30 years, and the clearest evidence for the increase has come from population-based studies of school-aged children and young adults. The strongest established risk factors for asthma are family history and sensitization to one or more indoor allergens. Some studies suggest that the increase in asthma has been part of an overall increase in atopic disease. The American data, however, suggest that hay fever was already common in 1960. Thus the primary increase has been in wheezing among allergic children. It seems unlikely that increases in mite, cockroach, and domestic animal allergens have been sufficient to explain the scale or the consistency of the increase in asthma prevalence. The challenge is to identify a change that could have increased inflammation of the lungs or lowered the threshold for wheezing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9848019     DOI: 10.1097/00008480-199810060-00010

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  9 in total

Review 1.  The role of allergens in the induction of asthma.

Authors:  Thomas A E Platts-Mills
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

2.  Galactose-α-1,3-galactose-specific IgE is associated with anaphylaxis but not asthma.

Authors:  Scott P Commins; Libby A Kelly; Eva Rönmark; Hayley R James; Shawna L Pochan; Edward J Peters; Bo Lundbäck; Lucy W Nganga; Philip J Cooper; Janelle M Hoskins; Saju S Eapen; Luis A Matos; Dane C McBride; Peter W Heymann; Judith A Woodfolk; Matthew S Perzanowski; Thomas A E Platts-Mills
Journal:  Am J Respir Crit Care Med       Date:  2012-01-26       Impact factor: 21.405

Review 3.  The indoor air and asthma: the role of cat allergens.

Authors:  Libby A Kelly; Elizabeth A Erwin; Thomas A E Platts-Mills
Journal:  Curr Opin Pulm Med       Date:  2012-01       Impact factor: 3.155

4.  Physical deconditioning as a cause of breathlessness among obese adolescents with a diagnosis of asthma.

Authors:  Yun M Shim; Autumn Burnette; Sean Lucas; Richard C Herring; Judith Weltman; James T Patrie; Arthur L Weltman; Thomas A Platts-Mills
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

5.  Differences in both prevalence and titre of specific immunoglobulin E among children with asthma in affluent and poor communities within a large town in Ghana.

Authors:  W Stevens; E Addo-Yobo; J Roper; A Woodcock; H James; T Platts-Mills; A Custovic
Journal:  Clin Exp Allergy       Date:  2011-08-02       Impact factor: 5.018

6.  The Seattle-King County healthy homes project: implementation of a comprehensive approach to improving indoor environmental quality for low-income children with asthma.

Authors:  James K Krieger; Tim K Takaro; Carol Allen; Lin Song; Marcia Weaver; Sanders Chai; Phillip Dickey
Journal:  Environ Health Perspect       Date:  2002-04       Impact factor: 9.031

7.  Assessment of personal and community-level exposures to particulate matter among children with asthma in Detroit, Michigan, as part of Community Action Against Asthma (CAAA).

Authors:  Gerald J Keeler; Timothy Dvonch; Fuyuen Y Yip; Edith A Parker; Barbara A Isreal; Frank J Marsik; Masako Morishita; James A Barres; Thomas G Robins; Wilma Brakefield-Caldwell; Mathew Sam
Journal:  Environ Health Perspect       Date:  2002-04       Impact factor: 9.031

Review 8.  The relevance of allergen exposure to the development of asthma in childhood.

Authors:  T A Platts-Mills; G Rakes; P W Heymann
Journal:  J Allergy Clin Immunol       Date:  2000-02       Impact factor: 10.793

Review 9.  Aluminum Adjuvant-Containing Vaccines in the Context of the Hygiene Hypothesis: A Risk Factor for Eosinophilia and Allergy in a Genetically Susceptible Subpopulation?

Authors:  Todd D Terhune; Richard C Deth
Journal:  Int J Environ Res Public Health       Date:  2018-05-03       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.